Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026)
Elutia (ELUT) reported Depreciation & Amortization (CF) of $330000.0 for Q1 2026, down 61.98% on a YoY basis from $868000.0 in Q1 2025, and up 11.11% sequentially from $297000.0 in Q4 2025.
Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $330000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 61.98% year-over-year to $330000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 34.96% YoY), and the FY2025 full-year result was $2.8 million, down 19.3% from the prior year.
- Depreciation & Amortization (CF) improved to $330000.0 in Q1 2026, from $297000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $954000.0 in Q2 2023 to a low of $297000.0 in Q4 2025.
- A 5-year average of $826294.1 and a median of $892000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 3.48% in 2025, while the deepest fall reached 65.59% in 2025.
- Tracing ELUT's Depreciation & Amortization (CF) over 5 years: stood at $937000.0 in 2022, then slipped by 4.59% to $894000.0 in 2023, then slipped by 3.47% to $863000.0 in 2024, then sank by 65.59% to $297000.0 in 2025, then climbed by 11.11% to $330000.0 in 2026.
- Business Quant data shows ELUT's Depreciation & Amortization (CF) at $330000.0 in Q1 2026, $297000.0 in Q4 2025, and $728000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 894,000.00 |
| Dec 31, 2023 | 894,000.00 |